← Back to Search

Sulfur hexafluoride lipid-type A microspheres for Appendicitis

Phase 2
Waitlist Available
Led By Tolulope Oyetunji, MD
Research Sponsored by Children's Mercy Hospital Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Study Summary

This study is evaluating whether contrast ultrasound may help improve the diagnosis of appendicitis in children.

Eligible Conditions
  • Appendicitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Children With an Accurate Diagnosis of Appendicitis.
Secondary outcome measures
Definitive Diagnosis
Number of Participants Who Required Additional CT Scan
Percentage of Negative Appendectomies
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
IV sulfur hexafluoride lipid-type A microspheres, 0.03 mL/kg, up to 2 doses per examination, total dose not to exceed 4.8 mL. Single examination per patient.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
FDA approved

Find a Location

Who is running the clinical trial?

Children's Mercy Hospital Kansas CityLead Sponsor
245 Previous Clinical Trials
935,762 Total Patients Enrolled
7 Trials studying Appendicitis
1,880 Patients Enrolled for Appendicitis
Tolulope Oyetunji, MDPrincipal InvestigatorChildren's Mercy Hospital Kansas City

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Role of Contrast Enhanced Ultrasound in Appendicitis
Tolulope Oyetunji 2019. "The Role of Contrast Enhanced Ultrasound in Appendicitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03687502.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top